Drug Trial Radar · NCT06658899
A Phase 2 Study of CRD-4730 in CPVT
Last checked: Nov 19, 2026Latest source record: Jul 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
12
Planned (sponsor's estimate)
Start
Dec 1, 2025
Primary completion
Apr 2027
Study completion Apr 2027
Sponsor
- Lead sponsor
- Cardurion Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, multicenter, double-blind, sponsor blinded, placebo-controlled, repeat-dose clinical study of CRD-4730 to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CRD-4730 to participants with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). Participants with CPVT will complete a 3-period, randomized 3-sequence study. Each participant will be randomized to one of the 3 sequences in which they will receive 2 different doses of CRD-4730 and 1 dose of matching placebo.
Conditions
- Catecholaminergic Polymorphic Ventricular Tachycardia
Interventions
CRD-4730Drug
Oral CRD-4730 in tablet form
PlaceboDrug
Placebo to match CRD-4730 in tablet form
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Outcome MeasuresTime frame: Baseline to Day 101
Locations
12 sites in 6 countries. Site status is shown where the registry gives one.
Cardurion Investigative Site
San Francisco, California · Recruiting
Cardurion Investigative Site
Morrisville, North Carolina · Recruiting
Cardurion Investigative Site
Houston, Texas · Recruiting
Cardurion Investigative Site
Salt Lake City, Utah · Recruiting
Cardurion Investigative Site
Madison, Wisconsin · Recruiting
Cardurion Investigative Site
Vancouver, British Columbia, Canada · Recruiting
Cardurion Investigative Site
Bron, France · Recruiting
Cardurion Investigative Site
Paris, France · Recruiting
Cardurion Investigative Site
Saint-Herblain, France · Recruiting
Cardurion Investigative Site
Pavia, Pavia, Italy · Recruiting
Cardurion Investigative Site
Amsterdam, North Holland, Netherlands · Recruiting
Cardurion Investigative Site
Esplugues de Llobregat, Barcelona, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.